Clinical Trial Update: Risk Minimisation Study for Diane-35 and Its Generics

View source ↗

Summary

This document reports the completion of a risk minimisation clinical trial for Diane-35 and its generic versions related to acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Diane-35 (ethinylestradiol / cyproterone acetate)

Snippet

Sponsor: Bayer | Conditions: Acne Vulgaris | Status: COMPLETED